System Architecture

Six modules. Zero blind spots. Already running.

Company Memory

When your VP of Strategy leaves, everything they knew leaves with them. Company Memory captures institutional knowledge, strategic context, and R&D intelligence — and keeps it alive through every transition.

Signal Monitoring

Your competitors filed a patent yesterday. A clinical trial in your space failed last week. An FDA guidance shifted your regulatory timeline. You found out about none of them. Cortex is already watching.

Regulatory Watch

FDA guidance changes don't wait for your quarterly review. They hit and your filing timeline shifts before anyone on your team reads the announcement. This module ensures you know first.

Market Belief Layer

By the time a market narrative shift appears in analyst reports, the positioning window is closed. This layer detects belief divergence while there is still time to act on it.

Executive Briefing Engine

Your board asks a question. Your team scrambles for two weeks to assemble an answer from scattered sources. The Briefing Engine delivers decision-ready intelligence on your cadence — before anyone has to ask.

Private Workspace

Every query you run on a shared AI platform trains someone else's model. Your strategic questions become another company's dataset. This workspace is yours alone. Isolated. Private. Non-negotiable.

Intelligence Flow

Internal context meets external signal. Decisions get made.

Internal Documents Competitor Signals Regulatory Feeds Clinical Trial Data Market Intelligence COMPANY MEMORY Knowledge Layer Strategic Context R&D Pipeline Organizational Intel SIGNAL FUSION Analysis Engine Context + Signal = Insight Executive Briefs Competitor Alerts Regulatory Memos INPUT SOURCES MEMORY LAYER FUSION ENGINE OUTPUTS
Outputs

Intelligence that arrives before you ask for it.

Competitor Movement Alert
Active
Entity
Vertex Pharmaceuticals
Signal
Acquired licensing rights for CF compound VX-659 expansion
Impact
HIGH Market position shift in CF therapeutics
Detected
2 hours ago
Regulatory Shift Memo
Active
Agency
FDA CDER
Subject
Updated guidance on clinical trial endpoints for neurodegenerative disorders
Impact
HIGH Requires protocol review
Action
Brief regulatory team on implications

Weekly Executive Brief

Curated digest of strategic movements, regulatory shifts, and decision-ready intelligence tailored to leadership priorities.

Asset Comparison Summary

Side-by-side analysis of competitive assets, development timelines, and strategic positioning across your market.

Market-Belief Divergence Signal

Alerts when market consensus begins shifting from established belief, signaling emerging opportunity or risk.

See how deployment works